Rare diseases
Investigational molecules
Locations
Back to Poland81 clinical trials in Ostrowiec Swietokrzyski, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Effectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
PolandStudy on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis
PolandStudy of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
PolandA Randomized Dose‑Ranging Study of Nalbuphine Hydrochloride Extended‑Release Tablets in Adults with Refractory Chronic Cough
PolandAsthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate
PolandStudy on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis
PolandStudy to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis
PolandStudy of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety
PolandA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
PolandComparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
PolandStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
PolandStudy of NT 201 compared to placebo in adults with moderate to severe platysma prominence
PolandThe busiest research cities in the country
What the registry says about research in the country
Important clinical research focusing on asthma and COPD management, including trials evaluating new inhaler formulations and innovative treatments for severe cases.
Studies include evaluation of triple therapy combinations and novel biological treatments for better disease control.
Comprehensive research into various skin conditions, with particular focus on atopic dermatitis, psoriasis, and other inflammatory skin disorders.
Trials examine both topical and systemic treatments, including novel biological therapies.
Innovative studies targeting atherosclerotic cardiovascular disease, focusing on prevention and treatment of major cardiovascular events.
Research includes evaluation of new compounds for managing cholesterol levels and preventing cardiovascular complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
